Market Summary
Dynavax Technologies Corporation (DVAX) Can Make the Dollars and Sense
Dynavax Technologies Corp. (NASDAQ: DVAX), a biotechnology company, has signed a contract to endow the company with the right to commercialize the hepatitis B vaccine in Germany and the EU in the future. Last week, Dynavax Technologies announced that it had entered into a collaboration
